Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Navigating the research–clinical interface in genomic medicine: analysis from the CSER Consortium

31 Aug 2017

Abstract excerpt

PurposeThe Clinical Sequencing Exploratory Research (CSER) Consortium encompasses nine National Institutes of Health-funded U-award projects investigating translation of genomic sequencing into clinical care. Previous literature has distinguished norms and rules governing research versus clinical care. This is the first study to explore how genomics investigators describe and navigate the research-clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Ethics in Clinical Research
Share to Genomics and Rare Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28858330
DOI: 10.1038/gim.2017.137

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Navigating the research–clinical interface in genomic medicine: analysis from the CSER ConsortiumPMID 28858330Read ↗

Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.Semantic proximity Read ↗

Implementation matters: How patient experiences differ when genetic counseling accompanies the return of genetic variants of uncertain significance.Semantic proximity Read ↗

Practical, ethical and regulatory considerations for the evolving medical and research genomics landscapeSemantic proximity Read ↗

Distinguishing research from clinical care in cancer genetics: Theoretical justifications and practical strategiesSemantic proximity Read ↗

Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratoriesSemantic proximity Read ↗

How do consent forms for diagnostic high‐throughput sequencing address unsolicited and secondary findings? A content analysisSemantic proximity Read ↗

The Challenge of Informed Consent and Return of Results in Translational Genomics: Empirical Analysis and RecommendationsSemantic proximity Read ↗

Building evidence and measuring clinical outcomes for genomic medicineSemantic proximity Read ↗

Examining Gaps in Institutional Policies for Clinical Genomic Data Sharing: A Cross-Jurisdictional StudySemantic proximity Read ↗

Sequencing for a Lifetime: Value, Feasibility, and the Governance Gap in Lifelong Genomic MedicineSemantic proximity Read ↗

Mapping the Ethics of Translational Genomics: Situating Return of Results and Navigating the Research-Clinical DivideSemantic proximity Read ↗

Primary Care Providers’ Perspectives on Receiving Tier 1 Genomic Results from a National Study – the Million Veteran Program Return Of Actionable Results (MVP-ROAR) StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.